NEW BRUNSWICK, NJ and ARMONK, NY--(Marketwire - January 25, 2008) - IBM (NYSE: IBM); The Cancer Institute of New Jersey (CINJ), which is a Center of Excellence of the University of Medicine and Dentistry-Robert Wood Johnson Medical School; and Rutgers, The State University of New Jersey, today announced a collaborative research effort to develop diagnostic tools which can improve the accuracy of predicting patients’ responses to treatment and related clinical outcomes. Through the use of advanced computer and imaging technologies that facilitate comparisons of cancerous tissues, cell and radiology studies, researchers and physicians expect to determine more accurate cancer prognoses, more personalized therapy planning and, subsequently, the discovery and development of new cancer drugs.
